Poster Author Of 2 e-Posters
210 - An Exclusively Oral Ribavirin Regimen for Respiratory Syncytial Virus Infection after Lung Transplantation is Effective and Cost-Efficient
Presentation Number
210
Speakers
Session Name
SESSION 56 - ORAL: The Pharmacist is IN! LVAD, Heart, and Lung Transplant Medication Questions Answered
Date
Fri, Apr 24, 2020
Time
10:30 AM - 12:15 PM
Authors
777 - Approaches to the Management of Sensitized Lung Transplant Candidates: Findings from an International Survey
Presentation Number
777
Session Name
POSTER SESSION 1 - POSTER SESSION: Lung Failure/Transplantation - Adult
Date
Wed, Apr 22, 2020
Time
06:00 PM - 07:15 PM
Authors
- M. Aversa, New York, NY, United States of America
- D. Darley, Toronto, ON, Canada
- A. Hirji, Edmonton, AB, Canada
- L. Snyder, Durham, NC, United States of America
- D. Lyu, Ann Arbor, MI, United States of America
- F. Parquin, Suresnes, France
- M. Perch, Copenhagen, Denmark
- H. Goldberg, Boston, MA, United States of America
- J. Lee, Philadelphia, PA, United States of America
- R. Hachem, Saint Louis, MO, United States of America
- D. Levine, San Antonio, TX, United States of America
- L. Benvenuto, New York, NY, United States of America
- S. Arcasoy, New York, NY, United States of America
- L. Singer, Toronto, ON, Canada